Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A new compound effectively inhibits human 5α-reductase 1.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Dutasteride and finasteride affect different cell types differently.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride may improve prostate cancer treatment outcomes.

We need better ways to test and understand SARMs to make safer and more effective treatments.

MC4R gene variants not linked to female hair loss.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

New compounds with carborane showed anti-androgen effects similar to flutamide.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.